monkey pox testing market research, monkey pox testing market size, global monkey pox testing market us, monkey pox testing market segment analysis, monkey pox testing market report, monkey pox testing market insights
At what pace is the monkey pox testing market growing, and what is its estimated value?
The monkey pox testing market size has grown steadily in recent years. It will grow from $1.46 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to increasing government funding and initiatives, increasing demand to provide rapid tests, increasing testing capacity, increasing research and development, and increasing public awareness campaigns.
The monkey pox testing market size is expected to see steady growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to rising healthcare expenditures, development of point-of-care (POC) tests, growth in at-home testing kits, focus on accessibility and affordability, and healthcare infrastructure improvement. Major trends in the forecast period include integration of testing with surveillance systems, integration with digital health tools, technological advancements, integration into public health systems and advancements in diagnostic research.
Get Your Free Sample of The Global Monkey Pox Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18817&type=smp
How have varous drivers impacted the growth of the monkey pox testing market?
The increasing incidence of monkey pox disease is expected to propel the growth of the monkey pox testing market going forward. Monkeypox is a rare viral disease caused by the monkeypox virus, a member of the orthodox virus genus related to the smallpox virus. The rise in monkeypox cases is due to increased human-to-human transmission, global travel, and reduced immunity from discontinued smallpox vaccination programs. Monkeypox testing helps by identifying infected individuals early, allowing for timely treatment and isolation to prevent further spread of the disease. It also aids in tracking outbreaks and understanding the virus’s transmission patterns. For instance, in May 2022, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, from January to April 2022, there were 1,152 suspected monkeypox cases, leading to 55 deaths and a case-fatality rate of 4.8%, spread across 54 health zones in 14 provinces. Further, in comparison to the same period in 2021, there is an increase of 138 suspected cases and 14 deaths, resulting in a higher case-fatality rate of 10.1%. Therefore, the increasing incidence of monkey pox disease is driving the growth of the monkey pox testing market.
What are the primary segments of the monkey pox testing market?
The monkey pox testing market covered in this report is segmented –
1) By Technology: Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Other Technologies
2) By Mode: Laboratory Testing, Point Of Care Testing
3) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Uses
Subsegments:
1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Multiplex PCR
2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays, Rapid Antigen Detection Kits
3) By Other Technologies: ELISA (Enzyme-Linked Immunosorbent Assay), CRISPR-based Testing, Serological Tests (Antibody Detection), Nucleic Acid Sequence-Based Amplification (NASBA)
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report
Which firms are leading the monkey pox testing market?
Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.
How will industry trends affect the trajectory of the monkey pox testing market?
Major companies operating in the monkey pox testing market are focusing on developing advanced diagnostic solutions, such as saliva-based monkey pox testing, to enhance accuracy, convenience, and accessibility. Saliva-based monkey pox testing is a diagnostic method that uses saliva samples to detect the presence of the monkeypox virus. For instance, in July 2022, Flow Health, a US-based medical laboratory, launched the saliva-based (polymerase chain reaction) PCR test for monkeypox, revolutionizing the testing process by offering a more convenient and non-invasive method for virus detection. This innovative test stands out with its high sensitivity and specificity, rapid genetic material amplification, and versatility for various applications. It allows for quantitative analysis of viral loads and direct pathogen detection, all while simplifying sample collection. One of its key advantages is the ability to test individuals before visible lesions appear, which is crucial for early detection and reducing virus transmission.
Which geographic trends are shaping the monkey pox testing market, and which region has the highest market share?
North America was the largest region in the monkey pox testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Monkey Pox Testing Market Report 2025 Offer?
The monkey pox testing market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Monkeypox testing refers to the diagnostic process used to detect the presence of the monkeypox virus in an individual. This testing is crucial for identifying and confirming cases of monkeypox, a viral zoonotic disease that can be transmitted from animals to humans and between humans.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18817
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
